List of Tables
Table 1. Global Anti-Inflammatory and Analgesic Gel Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Anti-Inflammatory and Analgesic Gel Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Anti-Inflammatory and Analgesic Gel Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Anti-Inflammatory and Analgesic Gel Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Anti-Inflammatory and Analgesic Gel Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Anti-Inflammatory and Analgesic Gel Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
Table 7. Global Anti-Inflammatory and Analgesic Gel Sales by Region (2020-2025) & (K Units)
Table 8. Global Anti-Inflammatory and Analgesic Gel Sales by Region (2026-2031) & (K Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Anti-Inflammatory and Analgesic Gel Sales by Manufacturers (2020-2025) & (K Units)
Table 11. Global Anti-Inflammatory and Analgesic Gel Sales Share by Manufacturers (2020-2025)
Table 12. Global Anti-Inflammatory and Analgesic Gel Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Anti-Inflammatory and Analgesic Gel Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Anti-Inflammatory and Analgesic Gel by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-Inflammatory and Analgesic Gel as of 2024)
Table 16. Global Anti-Inflammatory and Analgesic Gel Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Anti-Inflammatory and Analgesic Gel Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
Table 18. Key Manufacturers Anti-Inflammatory and Analgesic Gel Manufacturing Base and Headquarters
Table 19. Global Anti-Inflammatory and Analgesic Gel Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Anti-Inflammatory and Analgesic Gel Sales by Type (2020-2025) & (K Units)
Table 23. Global Anti-Inflammatory and Analgesic Gel Sales by Type (2026-2031) & (K Units)
Table 24. Global Anti-Inflammatory and Analgesic Gel Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Anti-Inflammatory and Analgesic Gel Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Anti-Inflammatory and Analgesic Gel ASP by Type (2020-2031) & (US$/Unit)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Anti-Inflammatory and Analgesic Gel Sales by Application (2020-2025) & (K Units)
Table 29. Global Anti-Inflammatory and Analgesic Gel Sales by Application (2026-2031) & (K Units)
Table 30. Anti-Inflammatory and Analgesic Gel High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Anti-Inflammatory and Analgesic Gel Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Anti-Inflammatory and Analgesic Gel Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Anti-Inflammatory and Analgesic Gel ASP by Application (2020-2031) & (US$/Unit)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Anti-Inflammatory and Analgesic Gel Growth Accelerators and Market Barriers
Table 37. North America Anti-Inflammatory and Analgesic Gel Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Anti-Inflammatory and Analgesic Gel Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Anti-Inflammatory and Analgesic Gel Growth Accelerators and Market Barriers
Table 40. Europe Anti-Inflammatory and Analgesic Gel Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Anti-Inflammatory and Analgesic Gel Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Anti-Inflammatory and Analgesic Gel Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Anti-Inflammatory and Analgesic Gel Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Anti-Inflammatory and Analgesic Gel Growth Accelerators and Market Barriers
Table 45. Southeast Asia Anti-Inflammatory and Analgesic Gel Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Anti-Inflammatory and Analgesic Gel Investment Opportunities and Key Challenges
Table 47. Central and South America Anti-Inflammatory and Analgesic Gel Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Anti-Inflammatory and Analgesic Gel Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Anti-Inflammatory and Analgesic Gel Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. Novartis Corporation Information
Table 51. Novartis Description and Major Businesses
Table 52. Novartis Product Models, Descriptions and Specifications
Table 53. Novartis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 54. Novartis Sales Value Proportion by Product in 2024
Table 55. Novartis Sales Value Proportion by Application in 2024
Table 56. Novartis Sales Value Proportion by Geographic Area in 2024
Table 57. Novartis Anti-Inflammatory and Analgesic Gel SWOT Analysis
Table 58. Novartis Recent Developments
Table 59. Pfizer Corporation Information
Table 60. Pfizer Description and Major Businesses
Table 61. Pfizer Product Models, Descriptions and Specifications
Table 62. Pfizer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 63. Pfizer Sales Value Proportion by Product in 2024
Table 64. Pfizer Sales Value Proportion by Application in 2024
Table 65. Pfizer Sales Value Proportion by Geographic Area in 2024
Table 66. Pfizer Anti-Inflammatory and Analgesic Gel SWOT Analysis
Table 67. Pfizer Recent Developments
Table 68. GlaxoSmithKline Corporation Information
Table 69. GlaxoSmithKline Description and Major Businesses
Table 70. GlaxoSmithKline Product Models, Descriptions and Specifications
Table 71. GlaxoSmithKline Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 72. GlaxoSmithKline Sales Value Proportion by Product in 2024
Table 73. GlaxoSmithKline Sales Value Proportion by Application in 2024
Table 74. GlaxoSmithKline Sales Value Proportion by Geographic Area in 2024
Table 75. GlaxoSmithKline Anti-Inflammatory and Analgesic Gel SWOT Analysis
Table 76. GlaxoSmithKline Recent Developments
Table 77. Johnson & Johnson Corporation Information
Table 78. Johnson & Johnson Description and Major Businesses
Table 79. Johnson & Johnson Product Models, Descriptions and Specifications
Table 80. Johnson & Johnson Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. Johnson & Johnson Sales Value Proportion by Product in 2024
Table 82. Johnson & Johnson Sales Value Proportion by Application in 2024
Table 83. Johnson & Johnson Sales Value Proportion by Geographic Area in 2024
Table 84. Johnson & Johnson Anti-Inflammatory and Analgesic Gel SWOT Analysis
Table 85. Johnson & Johnson Recent Developments
Table 86. Sanofi Corporation Information
Table 87. Sanofi Description and Major Businesses
Table 88. Sanofi Product Models, Descriptions and Specifications
Table 89. Sanofi Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Sanofi Sales Value Proportion by Product in 2024
Table 91. Sanofi Sales Value Proportion by Application in 2024
Table 92. Sanofi Sales Value Proportion by Geographic Area in 2024
Table 93. Sanofi Anti-Inflammatory and Analgesic Gel SWOT Analysis
Table 94. Sanofi Recent Developments
Table 95. Sun Pharmaceutical Industries Corporation Information
Table 96. Sun Pharmaceutical Industries Description and Major Businesses
Table 97. Sun Pharmaceutical Industries Product Models, Descriptions and Specifications
Table 98. Sun Pharmaceutical Industries Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 99. Sun Pharmaceutical Industries Recent Developments
Table 100. AdvaCare Pharma Corporation Information
Table 101. AdvaCare Pharma Description and Major Businesses
Table 102. AdvaCare Pharma Product Models, Descriptions and Specifications
Table 103. AdvaCare Pharma Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 104. AdvaCare Pharma Recent Developments
Table 105. Topical BioMedics Corporation Information
Table 106. Topical BioMedics Description and Major Businesses
Table 107. Topical BioMedics Product Models, Descriptions and Specifications
Table 108. Topical BioMedics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 109. Topical BioMedics Recent Developments
Table 110. Health & Beyond Corporation Information
Table 111. Health & Beyond Description and Major Businesses
Table 112. Health & Beyond Product Models, Descriptions and Specifications
Table 113. Health & Beyond Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 114. Health & Beyond Recent Developments
Table 115. Troy Healthcare Corporation Information
Table 116. Troy Healthcare Description and Major Businesses
Table 117. Troy Healthcare Product Models, Descriptions and Specifications
Table 118. Troy Healthcare Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 119. Troy Healthcare Recent Developments
Table 120. Glydex Pharmaceutical Corporation Information
Table 121. Glydex Pharmaceutical Description and Major Businesses
Table 122. Glydex Pharmaceutical Product Models, Descriptions and Specifications
Table 123. Glydex Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 124. Glydex Pharmaceutical Recent Developments
Table 125. Microwin Corporation Information
Table 126. Microwin Description and Major Businesses
Table 127. Microwin Product Models, Descriptions and Specifications
Table 128. Microwin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 129. Microwin Recent Developments
Table 130. Key Raw Materials Distribution
Table 131. Raw Materials Key Suppliers
Table 132. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 133. Milestones in Production Technology Evolution
Table 134. Distributors List
Table 135. Market Trends and Market Evolution
Table 136. Market Drivers and Opportunities
Table 137. Market Challenges, Risks, and Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Anti-Inflammatory and Analgesic Gel Product Picture
Figure 2. Global Anti-Inflammatory and Analgesic Gel Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Prescription Pain Relief Gel Product Picture
Figure 4. Over-the-Counter Pain Relief Gel Product Picture
Figure 5. Global Anti-Inflammatory and Analgesic Gel Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 6. Hospital
Figure 7. Home Care
Figure 8. Other
Figure 9. Anti-Inflammatory and Analgesic Gel Report Years Considered
Figure 10. Global Anti-Inflammatory and Analgesic Gel Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Anti-Inflammatory and Analgesic Gel Revenue (2020-2031) & (US$ Million)
Figure 12. Global Anti-Inflammatory and Analgesic Gel Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 13. Global Anti-Inflammatory and Analgesic Gel Revenue Market Share by Region (2020-2031)
Figure 14. Global Anti-Inflammatory and Analgesic Gel Sales (2020-2031) & (K Units)
Figure 15. Global Anti-Inflammatory and Analgesic Gel Sales (CAGR) by Region (2020-2031) (K Units)
Figure 16. Global Anti-Inflammatory and Analgesic Gel Sales Market Share by Region (2020-2031)
Figure 17. Top 5 and Top 10 Manufacturers Anti-Inflammatory and Analgesic Gel Sales Volume Market Share in 2024
Figure 18. Global Anti-Inflammatory and Analgesic Gel Revenue Market Share Ranking (2024)
Figure 19. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 20. Prescription Pain Relief Gel Revenue Market Share by Manufacturer in 2024
Figure 21. Over-the-Counter Pain Relief Gel Revenue Market Share by Manufacturer in 2024
Figure 22. Global Anti-Inflammatory and Analgesic Gel Sales Market Share by Type (2020-2031)
Figure 23. Global Anti-Inflammatory and Analgesic Gel Revenue Market Share by Type (2020-2031)
Figure 24. Global Anti-Inflammatory and Analgesic Gel Sales Market Share by Application (2020-2031)
Figure 25. Global Anti-Inflammatory and Analgesic Gel Revenue Market Share by Application (2020-2031)
Figure 26. North America Anti-Inflammatory and Analgesic Gel Sales YoY (2020-2031) & (K Units)
Figure 27. North America Anti-Inflammatory and Analgesic Gel Revenue YoY (2020-2031) & (US$ Million)
Figure 28. North America Top 5 Manufacturers Anti-Inflammatory and Analgesic Gel Sales Revenue (US$ Million) in 2024
Figure 29. North America Anti-Inflammatory and Analgesic Gel Sales Volume (K Units) by Type (2020- 2031)
Figure 30. North America Anti-Inflammatory and Analgesic Gel Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 31. North America Anti-Inflammatory and Analgesic Gel Sales Volume (K Units) by Application (2020-2031)
Figure 32. North America Anti-Inflammatory and Analgesic Gel Sales Revenue (US$ Million) by Application (2020-2031)
Figure 33. US Anti-Inflammatory and Analgesic Gel Revenue (2020-2031) & (US$ Million)
Figure 34. Canada Anti-Inflammatory and Analgesic Gel Revenue (2020-2031) & (US$ Million)
Figure 35. Mexico Anti-Inflammatory and Analgesic Gel Revenue (2020-2031) & (US$ Million)
Figure 36. Europe Anti-Inflammatory and Analgesic Gel Sales YoY (2020-2031) & (K Units)
Figure 37. Europe Anti-Inflammatory and Analgesic Gel Revenue YoY (2020-2031) & (US$ Million)
Figure 38. Europe Top 5 Manufacturers Anti-Inflammatory and Analgesic Gel Sales Revenue (US$ Million) in 2024
Figure 39. Europe Anti-Inflammatory and Analgesic Gel Sales Volume (K Units) by Type (2020-2031)
Figure 40. Europe Anti-Inflammatory and Analgesic Gel Sales Revenue (US$ Million) by Type (2020-2031)
Figure 41. Europe Anti-Inflammatory and Analgesic Gel Sales Volume (K Units) by Application (2020-2031)
Figure 42. Europe Anti-Inflammatory and Analgesic Gel Sales Revenue (US$ Million) by Application (2020-2031)
Figure 43. Germany Anti-Inflammatory and Analgesic Gel Revenue (2020-2031) & (US$ Million)
Figure 44. France Anti-Inflammatory and Analgesic Gel Revenue (2020-2031) & (US$ Million)
Figure 45. U.K. Anti-Inflammatory and Analgesic Gel Revenue (2020-2031) & (US$ Million)
Figure 46. Italy Anti-Inflammatory and Analgesic Gel Revenue (2020-2031) & (US$ Million)
Figure 47. Russia Anti-Inflammatory and Analgesic Gel Revenue (2020-2031) & (US$ Million)
Figure 48. Asia-Pacific Anti-Inflammatory and Analgesic Gel Sales YoY (2020-2031) & (K Units)
Figure 49. Asia-Pacific Anti-Inflammatory and Analgesic Gel Revenue YoY (2020-2031) & (US$ Million)
Figure 50. Asia-Pacific Top 8 Manufacturers Anti-Inflammatory and Analgesic Gel Sales Revenue (US$ Million) in 2024
Figure 51. Asia-Pacific Anti-Inflammatory and Analgesic Gel Sales Volume (K Units) by Type (2020- 2031)
Figure 52. Asia-Pacific Anti-Inflammatory and Analgesic Gel Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 53. Asia-Pacific Anti-Inflammatory and Analgesic Gel Sales Volume (K Units) by Application (2020-2031)
Figure 54. Asia-Pacific Anti-Inflammatory and Analgesic Gel Sales Revenue (US$ Million) by Application (2020-2031)
Figure 55. Indonesia Anti-Inflammatory and Analgesic Gel Revenue (2020-2031) & (US$ Million)
Figure 56. Japan Anti-Inflammatory and Analgesic Gel Revenue (2020-2031) & (US$ Million)
Figure 57. South Korea Anti-Inflammatory and Analgesic Gel Revenue (2020-2031) & (US$ Million)
Figure 58. China Taiwan Anti-Inflammatory and Analgesic Gel Revenue (2020-2031) & (US$ Million)
Figure 59. India Anti-Inflammatory and Analgesic Gel Revenue (2020-2031) & (US$ Million)
Figure 60. Central and South America Anti-Inflammatory and Analgesic Gel Sales YoY (2020-2031) & (K Units)
Figure 61. Central and South America Anti-Inflammatory and Analgesic Gel Revenue YoY (2020-2031) & (US$ Million)
Figure 62. Central and South America Top 5 Manufacturers Anti-Inflammatory and Analgesic Gel Sales Revenue (US$ Million) in 2024
Figure 63. Central and South America Anti-Inflammatory and Analgesic Gel Sales Volume (K Units) by Type (2021-2031)
Figure 64. Central and South America Anti-Inflammatory and Analgesic Gel Sales Revenue (US$ Million) by Type (2020-2031)
Figure 65. Central and South America Anti-Inflammatory and Analgesic Gel Sales Volume (K Units) by Application (2020-2031)
Figure 66. Central and South America Anti-Inflammatory and Analgesic Gel Sales Revenue (US$ Million) by Application (2020-2031)
Figure 67. Brazil Anti-Inflammatory and Analgesic Gel Revenue (2020-2025) & (US$ Million)
Figure 68. Argentina Anti-Inflammatory and Analgesic Gel Revenue (2020-2025) & (US$ Million)
Figure 69. Middle East, and Africa Anti-Inflammatory and Analgesic Gel Sales YoY (2020-2031) & (K Units)
Figure 70. Middle East and Africa Anti-Inflammatory and Analgesic Gel Revenue YoY (2020-2031) & (US$ Million)
Figure 71. Middle East and Africa Top 5 Manufacturers Anti-Inflammatory and Analgesic Gel Sales Revenue (US$ Million) in 2024
Figure 72. Middle East and Africa Anti-Inflammatory and Analgesic Gel Sales Volume (K Units) by Type (2021-2031)
Figure 73. South America Anti-Inflammatory and Analgesic Gel Sales Revenue (US$ Million) by Type (2020-2031)
Figure 74. Middle East and Africa Anti-Inflammatory and Analgesic Gel Sales Volume (K Units) by Application (2020-2031)
Figure 75. Middle East and Africa Anti-Inflammatory and Analgesic Gel Sales Revenue (US$ Million) by Application (2020-2031)
Figure 76. GCC Countries Anti-Inflammatory and Analgesic Gel Revenue (2020-2025) & (US$ Million)
Figure 77. Turkey Anti-Inflammatory and Analgesic Gel Revenue (2020-2025) & (US$ Million)
Figure 78. Egypt Anti-Inflammatory and Analgesic Gel Revenue (2020-2025) & (US$ Million)
Figure 79. South Africa Anti-Inflammatory and Analgesic Gel Revenue (2020-2025) & (US$ Million)
Figure 80. Anti-Inflammatory and Analgesic Gel Industry Chain Mapping
Figure 81. Regional Anti-Inflammatory and Analgesic Gel Manufacturing Base Distribution (%)
Figure 82. Global Anti-Inflammatory and Analgesic Gel Production Market Share by Region (2020-2031)
Figure 83. Anti-Inflammatory and Analgesic Gel Production Process
Figure 84. Regional Anti-Inflammatory and Analgesic Gel Production Cost Structure
Figure 85. Channels of Distribution (Direct Vs Distribution)
Figure 86. Bottom-up and Top-down Approaches for This Report
Figure 87. Data Triangulation
Figure 88. Key Executives Interviewed
